These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2136987)

  • 1. Macrophage migration inhibition factor (MIF) in drug eruption.
    Halevy S; Grunwald MH; Sandbank M; Buimovice B; Joshua H; Livni E
    Arch Dermatol; 1990 Jan; 126(1):48-51. PubMed ID: 2136987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Macrophage migration inhibition factor as a diagnostic aid in drug eruptions].
    Halevy S; Grunwald MH; Sandbank M; Buimovice B; Livni E
    Harefuah; 1991 Sep; 121(5-6):147-9. PubMed ID: 1834535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generalized pustular drug eruptions: confirmation by in vitro tests.
    Lazarov A; Livni E; Halevy S
    J Eur Acad Dermatol Venereol; 1998 Jan; 10(1):36-41. PubMed ID: 9552755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A study of clinical significance of leucocyte migration test in drug eruption].
    Abe M; Uno K
    Arerugi; 1998 Dec; 47(12):1264-72. PubMed ID: 10028721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lichenoid eruption due to hydrochlorothiazide. Diagnostic aid of macrophage migration inhibition factor (MIF) test.
    Halevy S; Grunwald MH; Feuerman EJ; Livni E
    Ann Allergy; 1986 May; 56(5):402-5. PubMed ID: 3518549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two lymphokines (macrophage migration inhibition, leukocyte adherence inhibition factors) and carcinoembryonic antigen, in colorectal cancer and colonic premalignant lesions.
    Shkolnik T; Livni E; Reshef R; Lachter J; Eidelman S
    Am J Gastroenterol; 1987 Dec; 82(12):1275-8. PubMed ID: 3318403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of macrophage migration-inhibition factor and protection from challenge exposure in calves vaccinated with Salmonella typhimurium.
    Habasha FG; Smith BP; Schwartz L; Ardans A; Reina-Guerra M
    Am J Vet Res; 1985 Jul; 46(7):1415-21. PubMed ID: 3896069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parameters of T cell mediated immunity to commensal micro-organisms in patients with chronic purulent rhinosinusitis: a comparison between delayed type hypersensitivity skin test, lymphocyte transformation test and macrophage migration inhibition factor assay.
    van de Plassche-Boers EM; Drexhage HA; Kokjé-Kleingeld M; Leezenberg HA
    Clin Exp Immunol; 1986 Dec; 66(3):516-24. PubMed ID: 3552334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The migration inhibition factor test for identification of hypersensitivity reactions to drugs.
    Aderka D; Livni E; Sharon C; Pinkhas J
    Ann Allergy; 1986 Apr; 56(4):341-4. PubMed ID: 3963526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic differences between migration inhibitory factor (MIF) and IFN-gamma for macrophage activation. MIF and IFN-gamma synergize with lipid A to mediate migration inhibition but only IFN-gamma induces production of TNF-alpha and nitric oxide.
    Herriott MJ; Jiang H; Stewart CA; Fast DJ; Leu RW
    J Immunol; 1993 May; 150(10):4524-31. PubMed ID: 7683323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoriasiform eruption induced by anticonvulsants.
    Brenner S; Wolf R; Landau M; Politi Y
    Isr J Med Sci; 1994 Apr; 30(4):283-6. PubMed ID: 8175330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibition test of macrophage migration in the study of various dermatoses].
    Castells Rodellas A; Castel Rodo T
    Actas Dermosifiliogr; 1973; 64(7-8):323-34. PubMed ID: 4611152
    [No Abstract]   [Full Text] [Related]  

  • 13. Macrophage migration inhibition assay as a means of detecting lymphocyte sensitization to leukemic myeloblasts in neutropenic patients.
    Sidi Y; Livni E; Shaklai M; Pinkhas J
    Isr J Med Sci; 1981 Dec; 17(12):1119-21. PubMed ID: 7035400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of Helicobacter pylori infection on expression of macrophage migration inhibitory factor by T cells and macrophages in gastric mucosa.
    He XX; Yang J; Zheng XL; Ding YW; Shen QY; Liu W; Zhao YH
    Chin Med J (Engl); 2005 Jul; 118(14):1201-5. PubMed ID: 16117866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The pathogenic role of macrophage migration inhibitory factor in acute respiratory distress syndrome].
    Guo Y; Xie C
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Jun; 25(6):337-40. PubMed ID: 12126556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Products of activated lymphocytes: leukocyte inhibitory factor (LIF) distinct from migration inhibitory factor (MIF).
    Rocklin RE
    J Immunol; 1974 Apr; 112(4):1461-6. PubMed ID: 4592603
    [No Abstract]   [Full Text] [Related]  

  • 17. Macrophage migration inhibition factor test in breast tumors.
    Gutman H; Kott I; Rabinerson D; Reiss R
    Isr J Med Sci; 1986 Nov; 22(11):812-6. PubMed ID: 3793437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of transfer factor on lymphocyte function in anergic patients.
    Kirkpatrick CH; Rich RR; Smith TK
    J Clin Invest; 1972 Nov; 51(11):2948-58. PubMed ID: 5080419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The detection and evaluation of migration stimulatory factor in renal allograft recipients.
    Cerilli J; Fesperman DP
    Surgery; 1976 Jul; 80(1):92-7. PubMed ID: 775669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble lymphocytic mediators. I. Inhibition of macrophage migration inhibitory factor production by drugs.
    Pick E
    Immunology; 1974 Mar; 26(3):649-58. PubMed ID: 4369184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.